Both in Pharmaceuticals
Precigen vs Generate Biomedicines
Over the past year PGEN returned −26.2% and GENB returned −9.9%; their daily moves had a correlation of 0.37.
PGEN −26.2% GENB −9.9%Growth of $1, one year, split-adjusted
| Metric | PGEN | GENB |
|---|---|---|
| Price | $5.06 | $14.16 |
| Market cap | $1.81B | $1.82B |
| Today | −3.71% | +2.24% |
| 1 month | −33.0% | +2.6% |
| 6 months | +14.9% | — |
| Year to date | +20.9% | — |
| 1 year | +21.5% | — |
| Revenue growth (YoY) | +6322.7% | — |
| Gross margin | 94.9% | 100.0% |
| Net margin | 36.5% | −1065.2% |
| P/E (TTM) | — | — |
| Price / sales | 21.1× | — |
| Net cash | -$55.7M | $452.3M |
| Dividend yield | — | — |
| Volatility (60d) | 86.8% | — |
| Short % of float | 26.1% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).